Thread by @EMA_News

Watch live 🔴

We are now starting our regular press briefing on #COVID19 vaccines and treatments.

Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉ema.europa.eu/en/events/ema-…

Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser

The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser

EMA is evaluating an application for the use of a booster dose of Comirnaty (#COVID19vaccine developed by BionTech/Pfizer) to be given at least 6 months after the 2nd dose in people aged 16 years and older. Outcome expected within the next few weeks. #EMAPresser

Other manufacturers may soon submit data on a 3rd booster dose. Moderna has started submitting data from their clinical trial with booster doses.
EMA is closely working with @ECDC_EU to collect & review data on booster doses. #EMAPresser

EMA granted authorisations to additional manufacturing sites of #COVID19vaccines, to increase the supply for the ongoing vaccination campaigns. #PublicHealth #EMAPresser

Worldwide safety data show that the benefits of #COVID19vaccines are much greater than any possible side effects. #EMAPresser

EMA and the 🇪🇺 Member States continuously analyse reports of suspected #SideEffects to detect any potential new safety concern. EMA publishes regular safety updates for all authorised #COVID19vaccines: ema.europa.eu/en/human-regul…
#EMAPresser

Besides vaccines, therapeutics are needed for patients that get ill with #COVID19. EMA is reviewing extension of indication for 3 immunomodulatory agents to be used in hospitalised patients with COVID-19: ema.europa.eu/en/human-regul… #EMAPresser

4 antiviral monoclonal antibodies products are currently under EMA’s rolling review for treatment of mild #COVID19 to avoid disease progression, and in some cases for prevention of COVID-19: ema.europa.eu/en/human-regul… #EMAPresser